Trade Summary

6 days ago, Chu Yu-Waye, serving as Chief Medical Officer at Cytomx Therapeutics, Inc. (CTMX), sold 21,279 shares at $6.42 per share, for a total transaction value of $136,675.00. Following this transaction, Chu Yu-Waye now holds 189,446 shares of CTMX.

This sale represents a 10.00% decrease in Chu Yu-Waye's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 19, 2026, 2 days after the trade was made.

Cytomx Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.